By the end of 2008 the state was projected to employ 45,905 biopharma jobs, up from the roughly 30,000 recorded for 2001. The growth was far stronger than the state's declining overall employment.
A report from Deloitte Consulting also said the Council must help life-sci businesses find capital, equipment discounts, legal advice, trained workers, and clout with state and federal officials.
Massachusetts Biotech-Labor Dispute, Lexington (Mass.) Technology Park, Pfizer-Wyeth Merger
The five-year purchasing deal is worth up to around $250 million to Thermo Fisher Scientific.
The Cambridge City Council approved the REIT's request to rezone 15.7 acres in an East Cambridge neighborhood to accommodate the $1 billion, 1.8 million-square-foot campus in exchange for including a greater mix of uses in the plan.
Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.
The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.